NeutriSci Closes Private Placement

 In Press Release

Vancouver, British Columbia – July 25, 2016 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU) announces that it has completed a non-brokered private placement in which it raised gross proceeds of $469,000.

In connection with the offering, NeutriSci issued 4,690,000 units at a price of ten cents per unit, with each unit consisting of one common share and one half of one common share purchase warrant. Each full warrant entitles the holder to acquire one additional common share at a price of eighteen cents per share for a period of twelve months from the date of closing.

All securities issued in connection with the private placement are subject to a hold period until November 22, 2016. In connection with closing, the Company has issued 189,000 common shares as compensation for subscriptions from qualified investors introduced to the Company.
The Company intends to use the proceeds of the financing for marketing of neuenergy™, and for general working capital purposes.

NeutriSci’s President Glen Rehman stated, “The sales team continues to have success in increasing our distribution channels, with neuenergy™ being stocked on more and more retail store shelves in Canada every day. As we ramp up our marketing initiatives we expect consumer awareness and sales to continue to increase as demand for the product also continues to increase. We continue to be excited about the direction neuenergy™ is taking.”

neuenergy™ is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products.

To find out more about neuenergy™, visit

On Behalf of the Board of Directors of

Glen Rehman
NeutriSci International Inc.
Tel: (403) 264-6320

For investor relations inquiries:

Skanderbeg Capital Advisors
Mario Vetro
O: 604‐687‐7130 x105
C: 778‐846‐9970

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focused on building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy™, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries. neuenergy™ contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine. neuenergy™ provides sustained energy and focus without sugar, calories, carbs or the jitters typically associated with energy products. For more information, visit:

Statements in this press release have not been evaluated by the Food and Drug Administration.  Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

Recent Posts
Contact Us

Send us a message and we'll get back to you as soon as possible.

Not readable? Change text. captcha txt

Start typing and press Enter to search